Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited
Year: 2019
Type: article
Abstract: Hypertension is the most prevalent cardiovascular risk factor [1]. Many people with hypertension also have comorbid conditions or risk factors for which novel treatment strategies are being tested ...
Source: Blood Pressure
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2944405016